The COVID-19 vaccine will not be available on a large scale in the U.S. until mid-2021, U.S. Department of Health officials said

On September 21, Assistant Secretary of Health And a member of the White House CoVID-19 Task Force said that a widely available coVID-19 vaccine would not be available until mid-2021.

The United States still has a long way to go before it can be widely distributed, Dr. Girol said: “It’s a fact that we won’t be able to make it widely available until the middle of 2021. From my point of view, if you can get about a few million doses in November or early December and get 5 or 10 percent of the population vaccinated, you can get 80 or 90 percent of the effect.”

And the effect that He’s referring to is a reduction in mortality. Front-line workers and vulnerable people are expected to be among the first to be injected. People with pre-existing conditions are also likely to receive some of the first doses of the vaccine to help stop transmission.

But There are no vaccines that have been developed and are awaiting approval, He said. He reiterated that vaccine development would not be subject to political interference and that science would prevail. (Yin Yue, CCTV reporter)